Upgrade to SI Premium - Free Trial

Intersect ENT (XENT) PT Raised to $41 at Guggenheim, 'Sinuva Deep Dive Suggests Significant Upside Potential'

December 11, 2017 6:48 AM
Guggenheim raised its price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change

Next Articles